The treatment of Graves’ disease in children and adolescents

키워드

참고문헌 (49)

1. Metso S, "Graves' disease", N Engl J Med, 359, pp.1408~1409 (2008)
2. Cooper DS, "Hyperthyroidism", Lancet, 362, pp.459~468 (2003)
3. Weetman AP, "Graves' disease", N Engl J Med, 343, pp.1236~1248 (2000)
4. Dotsch J, "Graves disease in childhood:a review of the options for diagnosis and treatment", Paediatr Drugs, 5, pp.95~102 (2003)
5. Cooper DS, "Antithyroid drugs", N Engl J Med, 352, pp.905~917 (2005)
6. Wilson R, "Evidence for carbimazole as an antioxidant?", Autoimmunity, 27, pp.149~153 (1998)
7. Weetman AP, "How antithyroid drugs work in Graves'disease", Clin Endocrinol, 37, pp.317~318 (1992)
8. Karras S, "Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts", J Pediatr Endocrinol Metab, 25, pp.623~630 (2012)
9. Rivkees SA, "Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children", J Clin Endocrinol Metab, 95, pp.3260~3267 (2010)
10. Nakamura H, "Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease", J Clin Endocrinol Metab, 92, pp.2157~2162 (2007)
11. Bahn Chair RS, "Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists", Thyroid, 21, pp.593~646 (2011)
12. Streetman DD, "Diagnosis and treatment of Graves disease", Ann Pharmacother, 37, pp.1100~1109 (2003)
13. Tajiri J, "Antithyroid drug-induced agranulocytosis:special reference to normal white blood cell count agranulocytosis", Thyroid, 14, pp.459~462 (2004)
14. Tajiri J, "Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring", Arch Intern Med, 150, pp.621~624 (1990)
15. Muldoon BT, "Management of Graves'disease: an overview and comparison of clinical practice guidelines with actual practice trends", Endocrinol Metab Clin North Am, 43, pp.495~516 (2014)
16. Abraham P, "Antithyroid drug regimen for treating Graves' hyperthyroidism", Cochrane Database Syst Rev, (1), pp.CD003420~ (2010)
17. Abraham P, "Antithyroid drug regimen for treating Graves' hyperthyroidism", Cochrane Database Syst Rev, (2), pp.CD003420~ (2004)
18. Kaguelidou F, "Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment", J Clin Endocrinol Metab, 93, pp.3817~3826 (2008)
19. Glaser NS, "Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study", Pediatrics, 121, pp.e481~e488 (2008)
20. Glaser NS, "Predictors of early remission of hyperthyroidism in children", J Clin Endocrinol Metab, 82, pp.1719~1726 (1997)
21. Hamburger JI, "Management of hyperthyroidism in children and adolescents", J Clin Endocrinol Metab, 60, pp.1019~1024 (1985)
22. Gastaldi R, "Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers", J Pediatr, 164, pp.1189~1194.e1 (2014)
23. Lippe BM, "Hyperthyroidism in children treated with long term medical therapy: twentyfive percent remission every two years", J Clin Endocrinol Metab, 64, pp.1241~1245 (1987)
24. Leger J, "Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national longterm cohort study", J Clin Endocrinol Metab, 97, pp.110~119 (2012)
25. Shulman DI, "Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy", Thyroid, 7, pp.755~760 (1997)
26. 이선희, "소아 및 청소년 그레이브스병 환자에서의 관해 예측 인자와 관해율", Korean Journal of Pediatrics, 52(9), pp.1021~1028 (2009), 대한소아과학회
27. 송승민, "한국 소아 및 청소년 Graves병의 자연 경과 및 예후 인자", Korean Journal of Pediatrics, 53(4), pp.585~591 (2010), 대한소아과학회
28. 김신미, "소아 그레이브스병 관해의 예측 지표", Annals of Pediatirc Endocrinology & Metabolism, 15(2), pp.100~105 (2010), 대한소아내분비학회
29. Mussa GC, "Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years", J Pediatr Endocrinol Metab, 12, pp.537~541 (1999)
30. Shibayama K, "Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease", Endocr J, 52, pp.505~510 (2005)
31. Feldt-Rasmussen U, "Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease", J Clin Endocrinol Metab, 78, pp.98~102 (1994)
32. Kamath C, "The role of thyrotrophin receptor antibody assays in graves' disease", J Thyroid Res, 2012, pp.525936~ (2012)
33. 김운곤, "소아 청소년 그레이브스병의 약물치료에 대한 임상 경과 및 예후에 영향을 미치는 인자", Annals of Pediatirc Endocrinology & Metabolism, 17(1), pp.33~38 (2012), 대한소아내분비학회[DOI]
34. Ma C, "Radioiodine treatment for pediatric Graves' disease", Cochrane Database Syst Rev, (3), pp.CD006294~ (2008)
35. Rivkees SA, "Influence of iodine-131 dose on the outcome of hyperthyroidism in children", Pediatrics, 111(4 Pt 1), pp.745~749 (2003)
36. Nebesio TD, "Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children", J Pediatr, 141, pp.99~103 (2002)
37. Boice JD Jr, "Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl", JAMA, 295, pp.1060~1062 (2006)
38. Boice JD Jr, "Radiation and thyroid cancer: what more can be learned?", Acta Oncol, 37, pp.321~324 (1998)
39. Chao M, "Radioiodine treatment for pediatric hyperthyroid Grave's disease", Eur J Pediatr, 168, pp.1165~1169 (2009)
40. Rivkees SA, "The management of hyperthyroidism in children with emphasis on the use of radioactive iodine", Pediatr Endocrinol Rev, 1(Suppl 2), pp.212~221 (2003)
41. Rivkees SA, "Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment", J Clin Endocrinol Metab, 83, pp.3767~3776 (1998)
42. Levy WJ, "Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment", Cleve Clin J Med, 55, pp.373~382 (1988)
43. Rivkees SA, "Pediatric Graves' disease: management in the post-propylthiouracil Era", Int J Pediatr Endocrinol, 2014, pp.10~ (2014)
44. Clark JD, "Iodine-131 therapy of hyperthyroidism in pediatric patients", J Nucl Med, 36, pp.442~445 (1995)
45. Rivkees SA, "An optimal treatment for pediatric Graves' disease is radioiodine", J Clin Endocrinol Metab, 92, pp.797~800 (2007)
46. Acharya SH, "Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review", Clin Endocrinol, 69, pp.943~950 (2008)
47. Sinha CK, "Thyroid surgery in children: clinical outcomes", Eur J Pediatr Surg (2014)
48. Palit TK, "The efficacy of thyroidectomy for Graves' disease: a meta-analysis", J Surg Res, 90, pp.161~165 (2000)
49. Annerbo M, "Management of Grave's disease is improved by total thyroidectomy", World J Surg, 36, pp.1943~1946 (2012)

관련 논문AI추천